Study design Phase 2 and 3 double blind, randomized, placebo-controlled clinical trials to assess the safety and immunogenicity of the inactivated influenza A / H5N1 vaccine (IVACFLU) - A / H5N1) produced by IVAC in healthy adults in Vietnam with 15 mcg vaccine dose.